Ignite Creation Date:
2024-05-05 @ 6:33 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00501852
Status:
COMPLETED
Last Update Posted:
2012-05-08
First Post:
2007-07-13
Brief Title:
Efficacy and Safety of Four Doses of Glycopyrronium Bromide NVA237 in Patients With Stable Chronic Obstructive Pulmonary Disease COPD in Comparison to an Active Comparator Tiotropium
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Organization Data
Organization:
Novartis
Class:
INDUSTRY
Study ID:
CNVA237A2205
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Novartis Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None